The Role of Clinical Equipoise and Practical Considerations in Deciding Whether to Continue to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”

American Journal of Bioethics 14 (4):59-60 (2014)
  Copy   BIBTEX

Abstract

No abstract

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,846

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Clinical Equipoise: Actual or Hypothetical Disagreement?Scott Gelfand - 2013 - Journal of Medicine and Philosophy 38 (6):590--604.
The morality of clinical research – a case study.Torbjörn Tännsjö - 1994 - Journal of Medicine and Philosophy 19 (1):7-21.
The Ethical Problems of the Open Label Extension Study.Kenneth Craig Micetich - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):410.
The real problem with equipoise.Winston Chiong - 2006 - American Journal of Bioethics 6 (4):37 – 47.
Speaking Off Label.Stephen R. Latham - 2010 - Hastings Center Report 40 (6):9-10.
So-called "clinical equipoise" and the argument from design.Fred Gifford - 2007 - Journal of Medicine and Philosophy 32 (2):135 – 150.
Uncertainty and the ethics of clinical trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.

Analytics

Added to PP
2014-04-15

Downloads
30 (#532,397)

6 months
4 (#787,709)

Historical graph of downloads
How can I increase my downloads?